产品详情
In vitro (25°C) | DMSO | 78 mg/mL (180.89 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 0.5% CMC+0.25% Tween 80 | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.19 mL | 115.96 mL | 231.91 mL |
0.5 mM | 4.64 mL | 23.19 mL | 46.38 mL |
1 mM | 2.32 mL | 11.6 mL | 23.19 mL |
5 mM | 0.46 mL | 2.32 mL | 4.64 mL |
*The above data is based on the productmolecular weight 431.2 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10089 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 431.2 |
Formula | C15H15FIN3O3 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 1236699-92-5 |
Synonyms | AS-703026, MSC1936369B |
SMILES | C1=CC(=C(C=C1I)F)NC2=C(C=CN=C2)C(=O)NC[C@@H](CO)O |
产品资料
产品标签
Product Questions
Product Questions
GDC-0973 (Cobimetinib)
GDC-0973 (Cobimetinib,RG7420)是一种有效且高度选择性的MEK1抑制剂,IC50为4.2 nM,对MEK1的选择性选择性是对MEK2的10…
GSK1120212 (JTP-74057, Trametinib)
GSK1120212 (JTP-74057,Trametinib)强烈阻止了MEK1和MEK2激酶的活性,而不是其他98种激酶的活性。
Ulixertinib (BVD-523, VRT752271)
Ulixertinib (BVD-523,VRT752271)是ERK蛋白激酶的吡咯抑制剂。
Cobimetinib (R-enantiomer)
Cobimetinib R-enantiomer是Cobimetinib的R对映异构体,Cobimetinib是一种有力的,高选择性的促分裂原活化蛋白激酶(…
PD184352 (CI-1040)
PD184352 (CI-1040)是一种ATP非竞争性MEK1/2抑制剂,在基于细胞的测定中,IC50为17 nM,对MEK1/2的选择性是对MEK5的1…
Refametinib (RDEA-119, BAY 86-9766)
Refametinib (RDEA-119,BAY 86-9766)是一种口服生物利用型选择性MEK抑制剂,EC50为 2.0-15 nM。具有潜在的抗肿瘤活性…